Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.
about
Adjunctive therapies for AIDS dementia complexClinical Trials in Neurovirology: Successes, Challenges, and PitfallsNeural correlates of working memory training in HIV patients: study protocol for a randomized controlled trial.Role of the macrophage inflammatory protein-1alpha/CC chemokine receptor 5 signaling pathway in the neuroinflammatory response and cognitive deficits induced by beta-amyloid peptideEnvelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury.Adjuvant therapies for HIV-associated neurocognitive disorders.Cognitive impairment in patients with AIDS - prevalence and severity.Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trialMolecular makeup of HIV-1 envelope protein.A pilot study of the effects of internet-based cognitive stimulation on neuropsychological function in HIV disease.Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action.Neurocognitive disturbances in HIV.Profound anti-HIV-1 activity of DAPTA in monocytes/macrophages and inhibition of CCR5-mediated apoptosis in neuronal cells.Neuropsychological impairment and gender differences in HIV-1 infection.Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial.
P2860
Q24242140-4C21E990-A35A-44FB-9812-29B2FB1CE185Q30250271-CFC772BB-EA12-451F-877B-D08351767C5DQ30391907-3522FA95-A283-450F-A6FC-D23562DDA5AAQ30490518-F7ADED43-00A4-44CD-BD25-DB8683BA1628Q34332239-93697B07-4A86-44C0-9BCF-7117CB405160Q34692081-1068D9B2-24AB-4CCC-A08F-45A2FC6AC9F9Q35057500-4FC7DE14-1B6B-4531-8BE9-0D2DDF05B43FQ35215604-9B83F4F3-73A7-4708-8FA6-FCD5F30AD518Q35888723-21327D12-C6AE-4FCF-B2C7-7E7EB0C13532Q36089644-453B6C12-C25D-469C-AEC5-1454CCCF4FAEQ36712281-24817AED-3F1D-432C-BF7A-04E37E2E1B1EQ37073656-2BEBD514-FAD5-4ABF-BC4F-DEB5451AC59DQ40042889-C9634042-8939-49E2-BAA6-06B9F2FAD715Q43923155-3991B0F2-070A-4B7B-8338-1DFDEBA7C733Q47590480-D561B5E8-558E-4808-B893-80FE3E9F8DBA
P2860
Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Randomized double-blind placeb ...... sociated cognitive impairment.
@ast
Randomized double-blind placeb ...... sociated cognitive impairment.
@en
Randomized double-blind placeb ...... sociated cognitive impairment.
@nl
type
label
Randomized double-blind placeb ...... sociated cognitive impairment.
@ast
Randomized double-blind placeb ...... sociated cognitive impairment.
@en
Randomized double-blind placeb ...... sociated cognitive impairment.
@nl
prefLabel
Randomized double-blind placeb ...... sociated cognitive impairment.
@ast
Randomized double-blind placeb ...... sociated cognitive impairment.
@en
Randomized double-blind placeb ...... sociated cognitive impairment.
@nl
P2093
P356
P1433
P1476
Randomized double-blind placeb ...... sociated cognitive impairment.
@en
P2093
Atkinson JH
Goldschmidts WL
Heseltine PN
Schneider L
P356
10.1001/ARCHNEUR.55.1.41
P577
1998-01-01T00:00:00Z